Oncolytics Biotech® Receives Special Protocol Assessment Agreement from FDA for Phase 3 Clinical Trial of Pelareorep In Metastatic Breast Cancer
Stock Information for Oncolytics Biotech Inc.
Loading
Please wait while we load your information from QuoteMedia.